Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Inhibition of Isorhamnetin on β-Catenin/Tcf Signaling and β-Catenin-Activated Melanogenesis

View through CrossRef
Activated β-catenin/T-cell factor (Tcf) signaling plays various roles in human cell mechanisms. We identified the inhibitory effect of isorhamnetin against β-catenin/Tcf signaling in β-catenin activated cells. Isorhamnetin inhibited the transcriptional activity of β-catenin/Tcf in HEK293 cells transiently transfected with a constitutively active mutant β-catenin gene. Also, isorhamnetin inhibited theβ-catenin-activated melanogenesis in B16F1 cells. Regarding the inhibitory mechanism, the shift assay showed that the binding of Tcf complexes with its specific DNA-binding sites was suppressed byisorhamnetin. Western blot analysis showed a decreased level of β-catenin in nucleus caused by isorhamnetin. These results suggest that the isorhamnetin acts as a negative regulator of β-catenin/Tcf signaling and its inhibitory mechanism is related to the decreased binding of β-catenin/Tcf complexes to consensus DNA.
Title: Inhibition of Isorhamnetin on β-Catenin/Tcf Signaling and β-Catenin-Activated Melanogenesis
Description:
Activated β-catenin/T-cell factor (Tcf) signaling plays various roles in human cell mechanisms.
We identified the inhibitory effect of isorhamnetin against β-catenin/Tcf signaling in β-catenin activated cells.
 Isorhamnetin inhibited the transcriptional activity of β-catenin/Tcf in HEK293 cells transiently transfected with a constitutively active mutant β-catenin gene.
 Also, isorhamnetin inhibited theβ-catenin-activated melanogenesis in B16F1 cells.
Regarding the inhibitory mechanism, the shift assay showed that the binding of Tcf complexes with its specific DNA-binding sites was suppressed byisorhamnetin.
Western blot analysis showed a decreased level of β-catenin in nucleus caused by isorhamnetin.
 These results suggest that the isorhamnetin acts as a negative regulator of β-catenin/Tcf signaling and its inhibitory mechanism is related to the decreased binding of β-catenin/Tcf complexes to consensus DNA.

Related Results

Bortezomib Induces Activation of b-Catenin/TCF Signaling Pathway in Multiple Myeloma
Bortezomib Induces Activation of b-Catenin/TCF Signaling Pathway in Multiple Myeloma
Abstract Abstract 1851 Background: The proteasome inhibitor Bortezomib (Bz) shows significant activity in Multipl...
Molecular circuitry of T-cell Development and Leukemogenesis
Molecular circuitry of T-cell Development and Leukemogenesis
Abstract T-cell Acute lymphoblastic leukemia (T-ALL) is an aggressive disease with only a 10% 5-year survival rate for patients over 60, due to genomic instability. ...
Activation of Wnt/β‐catenin/Tcf signaling in mouse skin carcinogenesis
Activation of Wnt/β‐catenin/Tcf signaling in mouse skin carcinogenesis
AbstractAlthough Wnt/β‐catenin/Tcf signaling pathway has been shown to be an important factor in the development of many malignancies including colorectal, ovarian, prostate, and m...
Novel preventive effect of isorhamnetin on electrical and structural remodeling in atrial fibrillation
Novel preventive effect of isorhamnetin on electrical and structural remodeling in atrial fibrillation
Abstract Isorhamnetin, a natural flavonoid, has strong antioxidant and antifibrotic effects, and a regulatory effect against Ca2+-handling. Atrial remodeling due to ...
The Hippo effector TAZ cooperates with oncogenic β-catenin in experimental and human hepatoblastoma development
The Hippo effector TAZ cooperates with oncogenic β-catenin in experimental and human hepatoblastoma development
Abstract Backgrounds: Hepatoblastoma (HB) is the most common pediatric liver tumor. Though Wnt/β-catenin and Hippo cascades are implicated in HB development, there is no st...
Abstract 630: The role of AKT pathway in β-catenin mutated hepatocellular carcinoma
Abstract 630: The role of AKT pathway in β-catenin mutated hepatocellular carcinoma
Abstract The Wnt/β-catenin and PI3K/AKT pathways are pivotal contributors to the development of the malignant phenotype in cancer. The activated Wnt/β-catenin pathwa...

Back to Top